In this study, we report an alternative inhibitor targeting PLK1 PBD which disrupted the formation of the PLK1/PRC1 signaling complex and inhibited the spatiotemporal coordination of PLK1 activity, resulting in mitotic catastrophe and enhanced sensitivity to chemotherapy in NSCLC. Here, PLK1 is linked to non-small cell lung carcinoma.